Facebook
Twitter
LinkedIn
Forward“Weighing In” on Glucagon-Like Peptide-1 Receptor Agonist Utilization Management Strategies and Real-World Clinical Outcomes
Pricing: Free for Members and $30 for Non-Members
Course Description
The skyrocketing demand for high-cost glucagon-like peptide-1 receptor agonists (GLP-1 RA) has led to concerns over drug shortages, pharmacy cost trends, and clinical benefit versus risk. While data continue to emerge for these weight loss treatments, are there approaches that health systems and payers can use to balance drug affordability and access?
This session will focus on clinical criteria recommendations, drug utilization management strategies, and real-world clinical outcomes data related to the use of GLP-1 RA in weight management.
Target Audience
Pharmacists who practice in managed care settings.
Learning Objectives
At the completion of this activity, participants should be able to:
- Describe clinical criteria and coverage recommendations from at least two U.S. or international payers on glucagon-like peptide-1 receptor agonists (GLP-1 RA) for weight management.
- Discuss design and implementation elements for at least two approaches to managing GLP-1 RA drug utilization.
- Summarize real-world effectiveness and safety outcomes data of GLP-1 RA for weight management.
Faculty
Jennifer Cashman, PharmD
Director, Drug Use Management
Kaiser Permanente
El Dorado Hills, CA
Thomas Delate, PhD, MS
Clinical Research Scientist
Kaiser Permanente
Aurora, CO
Catherine Pham, PharmD, MPH
Pharmacist Project Manager
Kaiser Permanente
Downey, CA
Moderator
Renee Rizzo Fleming, RPh, MBA
President
PRN Managed Care Consulting Services, LLC
East Amherst, New York
Financial Relationship Disclosures
| Faculty/Reviewer/Planner | Reported Relevant Financial Relationships |
| Jennifer Cashman, PharmD Faculty | Disclosed no relevant financial relationships. |
| Thomas Delate, PhD, MS Faculty | Disclosed no relevant financial relationships. |
| Catherine Pham, PharmD, MPH Faculty | Disclosed no relevant financial relationships. |
Ani Khachatourian | Disclosed no relevant financial relationships. |
| Jennifer Evans Planner | Disclosed no relevant financial relationships. |
- If applicable, relevant financial relationships have been mitigated and documented.
- Content has undergone a peer review to ensure content validity.
Accreditation:
The Academy of Managed Care Pharmacy (AMCP) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
ACPE UAN: 0233-0000-24-022-H01-P • Activity Type: Knowledge-Based
Contact Hours: 1.25
Release Date: May 3, 2024 • Expiration Date: December 31, 2025
Activity Fee: Free for Members and $30 for Non-Members
Participants should claim continuing pharmacy education (CPE) credit for this home study activity only if they have not claimed credit for the live activity presented at AMCP 2024. CPE credit will be processed through the AMCP Learn portal and reported directly to CPE Monitor. Please allow 72 hours for processing and posting in your NABP account.
To receive credit for an online activity you must:
- Review the full content of the activity.
- Successfully complete the post-test (required to pass with a score of 70% or higher, it may be taken a maximum of three times).
- Complete a specific activity evaluation.
Available Credit
- 1.25 ACPE
The Academy of Managed Care Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. - 1.25 Certificate of Completion
Price
Required Hardware/software
System Requirements Courses and learning activities are delivered via your Web browser and Acrobat PDF. For all activities, you should have a basic comfort level using a computer and navigating websites. View the minimum technical and system requirements for continuing education online learning activities